Ravi Yang Sarin - 17 Nov 2022 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Role
Director
Signature
By: Mark Hueppelsheuser For: Ravi Sarin
Issuer symbol
TOI
Transactions as of
17 Nov 2022
Net transactions value
$0
Form type
4
Filing time
21 Nov 2022, 16:35:07 UTC
Previous filing
23 Mar 2022
Next filing
21 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TOI Common Stock Award $0 +22,708 +98% $0.000000 45,899 17 Nov 2022 Direct F1
holding TOI Common Stock 4,109,771 17 Nov 2022 by LLC
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units that vest in full on May 17, 2023, subject to continued service with the Company through such vesting date.